Katherine Nicole Peake, Steven Tessier, Santo Longo, Deborah M Stahlnecker, Osamudiamen Idahosa, Thomas Zanders, Firas Ido
{"title":"Metformin toxicity in the intensive care unit: A case series and review of the literature.","authors":"Katherine Nicole Peake, Steven Tessier, Santo Longo, Deborah M Stahlnecker, Osamudiamen Idahosa, Thomas Zanders, Firas Ido","doi":"10.4103/ijciis.ijciis_46_23","DOIUrl":null,"url":null,"abstract":"<p><p>Metformin toxicity is a life-threatening condition with high morbidity and mortality. Toxicity predominantly occurs in the setting of acute renal dysfunction, as the drug is solely eliminated by the kidneys. While this risk is widely known to clinicians, diagnosing metformin toxicity is challenging because commercially available serum metformin levels require days to weeks to result. Therefore, the intensivist must rely on medical history, clinical presentation, and routine laboratory findings to make the preliminary diagnosis. Treatment of metformin toxicity includes supportive fluid hydration, vasopressors, and emergent hemodialysis (HD). We report three critically ill patients who had near-fatal severe metformin-induced lactic acidosis. Their metformin levels were markedly higher than the toxicity threshold reported by the Federal Drug Agency. These patients made a prompt and complete recovery after the initiation of HD. We also review the pathophysiology, clinical presentation, diagnosis, and treatment of metformin toxicity.</p>","PeriodicalId":13938,"journal":{"name":"International Journal of Critical Illness and Injury Science","volume":"14 1","pages":"51-58"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11073643/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Critical Illness and Injury Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijciis.ijciis_46_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/27 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Metformin toxicity is a life-threatening condition with high morbidity and mortality. Toxicity predominantly occurs in the setting of acute renal dysfunction, as the drug is solely eliminated by the kidneys. While this risk is widely known to clinicians, diagnosing metformin toxicity is challenging because commercially available serum metformin levels require days to weeks to result. Therefore, the intensivist must rely on medical history, clinical presentation, and routine laboratory findings to make the preliminary diagnosis. Treatment of metformin toxicity includes supportive fluid hydration, vasopressors, and emergent hemodialysis (HD). We report three critically ill patients who had near-fatal severe metformin-induced lactic acidosis. Their metformin levels were markedly higher than the toxicity threshold reported by the Federal Drug Agency. These patients made a prompt and complete recovery after the initiation of HD. We also review the pathophysiology, clinical presentation, diagnosis, and treatment of metformin toxicity.
二甲双胍中毒是一种危及生命的疾病,发病率和死亡率都很高。由于二甲双胍仅由肾脏排出,因此毒性主要发生在急性肾功能障碍的情况下。虽然临床医生都知道这种风险,但诊断二甲双胍中毒却很困难,因为市售的二甲双胍血清水平需要数天至数周才能得出结果。因此,重症监护医生必须依靠病史、临床表现和常规实验室检查结果来做出初步诊断。二甲双胍中毒的治疗包括支持性液体补液、血管加压和紧急血液透析(HD)。我们报告了三名重症患者因二甲双胍诱发乳酸酸中毒而濒临死亡。他们的二甲双胍水平明显高于联邦药品管理局报告的毒性阈值。这些患者在开始接受 HD 治疗后迅速完全康复。我们还回顾了二甲双胍中毒的病理生理学、临床表现、诊断和治疗。
期刊介绍:
IJCIIS encourages research, education and dissemination of knowledge in the field of Critical Illness and Injury Science across the world thus promoting translational research by striking a synergy between basic science, clinical medicine and public health. The Journal intends to bring together scientists and academicians in the emergency intensive care and promote translational synergy between Laboratory Science, Clinical Medicine and Public Health. The Journal invites Original Articles, Clinical Investigations, Epidemiological Analysis, Data Protocols, Case Reports, Clinical Photographs, review articles and special commentaries. Students, Residents, Academicians, Public Health experts and scientists are all encouraged to be a part of this initiative by contributing, reviewing and promoting scientific works and science.